Should Investors Be Angry With Big Pharma?

Some of the most prominent pharmaceutical companies -- including Dow Jones Industrial Average components Johnson & Johnson, Pfizer, and Merck -- heavily invest in marketing. In fact, the sales, marketing, and administrative expenses at many pharma companies exceed the R&D budget. As blockbuster drugs continue to lose patent exclusivity, is this really the best way for big pharma players to spend money? Should investors be upset, or is this a strategy that will build shareholder wealth over the long term?

In the following video, analyst Max Macaluso examines how large marketing budgets affect consumer behavior in the health-care sector and urges shareholders to think about this issue as they make investing decisions.

Large-cap health-care stocks like Johnson & Johnson, Pfizer, and Merck are traditionally known as defensive plays, but it'll take more than a few investments to save up for your retirement. Don't make the same mistakes as the masses and learn about The Shocking Can't-Miss Truth About Your Retirement. It won’t cost you a thing, but keep in mind that this report won't be available forever. Click here now to grab your copy today.

Max Macaluso has no positions in the stocks mentioned above. The Motley Fool owns shares of Johnson & Johnson. Motley Fool newsletter services recommend Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2036840, ~/Articles/ArticleHandler.aspx, 10/25/2016 10:41:11 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 hour ago Sponsored by:
DOW 18,169.27 -53.76 -0.30%
S&P 500 2,143.16 -8.17 -0.38%
NASD 5,283.40 -26.43 -0.50%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/25/2016 4:34 PM
^DJI $18169.27 Down -53.76 -0.30%
JNJ $113.96 Up +0.35 +0.31%
Johnson and Johnso… CAPS Rating: ****
MRK $61.95 Up +1.20 +1.98%
Merck and Co. CAPS Rating: ****
PFE $32.28 Up +0.15 +0.47%
Pfizer CAPS Rating: ****